News
- Author:
- Frieda Wiley
Publish date: September 30, 2024
While genetic testing may offer great potential for providing answers to patients and clinicians seeking insight into a rare disorder, the technolo...
Opinion
- Author:
- Frieda Wiley
Publish date: January 25, 2023
To celebrate our 30th year in print, Neurology Reviews invited experts to look back on the trajectories of various neurology subspecialties. In thi...
News
- Author:
- Frieda Wiley
Publish date: December 7, 2022
Dr. Louis Caplan looks back on the successes and failures in stroke research and treatment.
News
- Author:
- Frieda Wiley
Publish date: May 14, 2021
People of African descent and Latinx ethnicity tend to fare worse than other people of color and their White counterparts.
News
- Author:
- Frieda Wiley
Publish date: April 14, 2021
The CGRP receptor antagonist shows promise, but hurdles set up by insurance companies limit its potential.
News
- Author:
- Frieda Wiley
Publish date: March 8, 2021
Low rates of triptan adherence are likely caused by disappointing efficacy and/or unpleasant side effects rather than economic considerations.
News
- Author:
- Frieda Wiley
Publish date: March 19, 2020
"SCD reduces lifespan by 30 years, and that's very hard to quantify," says Dr. Ifeyinwa Osunkwo.
News
- Author:
- Frieda Wiley
Publish date: November 10, 2019
NATIONAL HARBOR, MD. – A study suggests that ambulatory surgery centers for orthopedic surgery deliver similar outcomes at a lower price than hospi...
News
- Author:
- Frieda Wiley
Publish date: November 6, 2019
NATIONAL HARBOR, MD. – The impact of drug shortages transcends the inability to supply patients with first-line or optimal therapy. Education is no...
News
- Author:
- Frieda Wiley
Publish date: October 31, 2019
NATIONAL HARBOR, MD. – Unclear drug pricing on prior authorizations creates a climate of frustration for clinicians and patients, but technology ma...
News
- Author:
- Frieda Wiley
Publish date: October 30, 2019
NATIONAL HARBOR, MD. – Selecting the ideal pharmacologic treatment for migraines remains a challenge because of hard-to-compare real-world evidence...
News
- Author:
- Frieda Wiley
Publish date: May 31, 2019
In 2016, Oregon became the first state to grant pharmacists authority to prescribe hormonal contraception without requiring consultation.
